Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 32 Colonic Neoplasms 20 Rectal Neoplasms 11 Carcinoma, Hepatocellular 7 Neoplasm Metastasis 5 Stomach Neoplasms 2 Neoplastic Cells, Circulating 2 Neoplasms 2 Liver Neoplasms 2 Recurrence 1 Peritoneal Neoplasms 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Oligometastatic Gastric Adenocarcinoma 1 Neuroendocrine Tumors 1 Neoplasms, Second Primary 1 Neoplasm, Residual 1 Neoplasm Recurrence, Local 1 Margins of Excision 1 Locally Advanced Rectal Cancer 1 Gastro-enteropancreatic neuroendocrine tumor 1 Gallbladder Neoplasms 1 Cholangiocarcinoma 1 Biliary Tract Neoplasms 1

Interventions

osimertinib 1 obinutuzumab 1 midostaurin 1 flumatinib 1 fludarabine 1 Radiotherapy 1 Oxaliplatin 1 Mitoxantrone 1 Mercaptopurine 1 Leucovorin 1 Irinotecan 1 Gemtuzumab 1 Folfox protocol 1 Fluorouracil 1 Drug Therapy 1 Daunorubicin 1 Cytarabine 1 Cyclophosphamide 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasm, Residual × Folfox protocol × Clear all

NCT05534087 2024-11-29

CLAUDIA

Seoul National University Hospital

Phase 3 Recruiting

Gastrointestinal

Colonic Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡